ECTRIMS eLearning

Patent foramen ovale: red flag in radiologically isolated syndrome
Author(s): ,
E Signoriello
Affiliations:
Multiple Sclerosis Center, II Division of Neurology, Seconda Università di Napoli
,
G Maresca
Affiliations:
Unità di Cardiologia Interventistica, Pineta Grande
,
M Cirillo
Affiliations:
Department of Surgical Medical Sciences, Neurological, Metabolic and Aging
,
G Signoriello
Affiliations:
Department of Mental Health and Preventive Medicine, Second University of Naples
,
A Negro
Affiliations:
Department of Surgical Medical Sciences, Neurological, Metabolic and Aging
,
E Koci
Affiliations:
Department of Advanced Biomedical Sciences, University Federico II
,
G Puoti
Affiliations:
II Division of Neurology, Second University of Naples
,
G Di Iorio
Affiliations:
II Division of Neurology, Second University of Naples
,
A Rapacciuolo
Affiliations:
Department of Advanced Biomedical Sciences, Federico II University
G Lus
Affiliations:
Multiple Sclerosis Center, II Division of Neurology, Second University of Naples, Naples, Italy
ECTRIMS Learn. Elisabetta S. 09/14/16; 145432; EP1337
Signoriello Elisabetta
Signoriello Elisabetta
Contributions
Abstract

Abstract: EP1337

Type: ePoster

Abstract Category: Clinical aspects of MS - Diagnosis and differential diagnosis

Objectives: To investigate the association of white matter lesions suggestive of demyelinating disease in magnetic resonance imaging (MRI) with patent foramen ovale (PFO) in migraine patients, with and without aura.

Materials: 22 migraine patients, 19 females and 3 males, with MRI evidence of white matter lesions suggestive of demyelinating disease. In 16 patients Barkhof criteria for dissemination in space were respected. For this reason, all the patients practiced further diagnostics including lumbar puncture, autoimmunity panel, thrombophilic evaluation, cardiological evaluation to detect the presence of PFO. Instrumental and clinical follow-up over three years was practiced and MIPAV software was used to analyse MRI imaging.

Results: 13 of 22 patients (59%) had PFO. Significant association was found between PFO and migraine with visual aura (p=0.03) and thrombophilia (p=0.04). None of them had oligoclonal bands in csf (p=0.014). No difference in number, volume and distribution of the lesions between the patients with and without PFO was noticed and 11 out of 16 patients carrying Barkhof criteria for disseminating in space had PFO. The follow up showed a stationary lesion load in all PFO patients, no infratentorial or spinal cord lesions and no enhancement at any time. The presence of PFO didn"t affect the lesions localization (periventricular, iuxtacortical, frontal, occipital, temporal or parietal) and corpus callosum lesion was never detected.

Discussion and conclusions: Migraine is often one of the main symptoms leading the patient to perform MRI, discovering, in most of the cases, white matter lesions of unspecific significance and placing always demyelinating diseases in differential diagnosis. Our study underlines the potential pathogenetic role of PFO in generating white matter lesions in migraine patients (59%), particularly in those with visual aura and thrombophilia. On the other side, with the evidence that 11 out of 16 patients carrying Barkhof criteria for disseminating in space had PFO and no clinical and instrumental diagnosis of demyelinating disease, we state that cardiologic evaluation represents a cardinal toll in differential diagnosis of RIS.

Disclosure: Elisabetta Signoriello: nothing to disclose

Abstract: EP1337

Type: ePoster

Abstract Category: Clinical aspects of MS - Diagnosis and differential diagnosis

Objectives: To investigate the association of white matter lesions suggestive of demyelinating disease in magnetic resonance imaging (MRI) with patent foramen ovale (PFO) in migraine patients, with and without aura.

Materials: 22 migraine patients, 19 females and 3 males, with MRI evidence of white matter lesions suggestive of demyelinating disease. In 16 patients Barkhof criteria for dissemination in space were respected. For this reason, all the patients practiced further diagnostics including lumbar puncture, autoimmunity panel, thrombophilic evaluation, cardiological evaluation to detect the presence of PFO. Instrumental and clinical follow-up over three years was practiced and MIPAV software was used to analyse MRI imaging.

Results: 13 of 22 patients (59%) had PFO. Significant association was found between PFO and migraine with visual aura (p=0.03) and thrombophilia (p=0.04). None of them had oligoclonal bands in csf (p=0.014). No difference in number, volume and distribution of the lesions between the patients with and without PFO was noticed and 11 out of 16 patients carrying Barkhof criteria for disseminating in space had PFO. The follow up showed a stationary lesion load in all PFO patients, no infratentorial or spinal cord lesions and no enhancement at any time. The presence of PFO didn"t affect the lesions localization (periventricular, iuxtacortical, frontal, occipital, temporal or parietal) and corpus callosum lesion was never detected.

Discussion and conclusions: Migraine is often one of the main symptoms leading the patient to perform MRI, discovering, in most of the cases, white matter lesions of unspecific significance and placing always demyelinating diseases in differential diagnosis. Our study underlines the potential pathogenetic role of PFO in generating white matter lesions in migraine patients (59%), particularly in those with visual aura and thrombophilia. On the other side, with the evidence that 11 out of 16 patients carrying Barkhof criteria for disseminating in space had PFO and no clinical and instrumental diagnosis of demyelinating disease, we state that cardiologic evaluation represents a cardinal toll in differential diagnosis of RIS.

Disclosure: Elisabetta Signoriello: nothing to disclose

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies